387525002: Hydrochlorothiazide (substance)

SNOMED CT Concept\Substance\...

\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Diuretic (substance)\Thiazide diuretic (substance)\Hydrochlorothiazide (substance)

\Substance categorised by structure\Chemical\Chemical categorized by structure (substance)\Organic compound\Organic cyclic compound\Heterocyclic compound\Thiazide\Benzothiadiazine (substance)\Hydrochlorothiazide (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2003. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

1461703016 Hydrochlorothiazide (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

1481615017 Hydrochlorothiazide en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

1492148015 HCTZ en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT core

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Hydrochlorothiazide (substance)	Is a	Thiazide diuretic (substance)	true	Inferred relationship	Some
Hydrochlorothiazide (substance)	Is a	Benzothiadiazine (substance)	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Hydrochlorothiazide 25 mg and valsartan 320 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Hydrochlorothiazide (substance)	Inferred relationship	Some	1
Hydrochlorothiazide 25 mg and valsartan 320 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Hydrochlorothiazide (substance)	Inferred relationship	Some	1
Hydrochlorothiazide 12.5 mg and valsartan 320 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Hydrochlorothiazide (substance)	Inferred relationship	Some	1
Product containing precisely aliskiren 150 milligram and hydrochlorothiazide 25 milligram/1 each conventional release oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Hydrochlorothiazide (substance)	Inferred relationship	Some	1
Product containing precisely enalapril 20 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Hydrochlorothiazide (substance)	Inferred relationship	Some	2
Product containing precisely enalapril 20 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Hydrochlorothiazide (substance)	Inferred relationship	Some	2
Product containing precisely enalapril 5 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Hydrochlorothiazide (substance)	Inferred relationship	Some	1
Hydrochlorothiazide 15 mg and methyldopa 250 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Hydrochlorothiazide (substance)	Inferred relationship	Some	1
Hydrochlorothiazide 30 mg and methyldopa 500 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Hydrochlorothiazide (substance)	Inferred relationship	Some	1
Hydrochlorothiazide 30 mg and methyldopa 500 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Hydrochlorothiazide (substance)	Inferred relationship	Some	1
Hydrochlorothiazide 50 mg and methyldopa 500 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Hydrochlorothiazide (substance)	Inferred relationship	Some	2
Product containing precisely hydrochlorothiazide 12.5 milligram and quinapril 20 milligram/1 each conventional release oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Hydrochlorothiazide (substance)	Inferred relationship	Some	1
Product containing precisely hydrochlorothiazide 12.5 milligram and quinapril 20 milligram/1 each conventional release oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Hydrochlorothiazide (substance)	Inferred relationship	Some	1
Hydrochlorothiazide 25 mg and reserpine 125 microgram oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Hydrochlorothiazide (substance)	Inferred relationship	Some	1
Hydrochlorothiazide 25 mg and reserpine 125 microgram oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Hydrochlorothiazide (substance)	Inferred relationship	Some	1
Hydrochlorothiazide 25 mg and spironolactone 25 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Hydrochlorothiazide (substance)	Inferred relationship	Some	2
Hydrochlorothiazide 25 mg and spironolactone 25 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Hydrochlorothiazide (substance)	Inferred relationship	Some	2
Hydrochlorothiazide 25 mg and triamterene 37.5 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Hydrochlorothiazide (substance)	Inferred relationship	Some	2
Hydrochlorothiazide 25 mg and triamterene 37.5 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Hydrochlorothiazide (substance)	Inferred relationship	Some	2
Hydrochlorothiazide 12.5 mg and valsartan 80 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Hydrochlorothiazide (substance)	Inferred relationship	Some	2
Hydrochlorothiazide 12.5 mg and valsartan 80 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Hydrochlorothiazide (substance)	Inferred relationship	Some	2
Hydrochlorothiazide 50 mg and spironolactone 50 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Hydrochlorothiazide (substance)	Inferred relationship	Some	2
Hydrochlorothiazide 50 mg and spironolactone 50 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Hydrochlorothiazide (substance)	Inferred relationship	Some	2
Product containing precisely eprosartan mesilate 600 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Hydrochlorothiazide (substance)	Inferred relationship	Some	1
Product containing precisely eprosartan mesilate 600 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Hydrochlorothiazide (substance)	Inferred relationship	Some	1
Hydrochlorothiazide 12.5 mg and moexipril hydrochloride 15 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Hydrochlorothiazide (substance)	Inferred relationship	Some	1
Hydrochlorothiazide 12.5 mg and moexipril hydrochloride 15 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Hydrochlorothiazide (substance)	Inferred relationship	Some	1
Product containing precisely hydrochlorothiazide 12.5 milligram and metoprolol tartrate 50 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Hydrochlorothiazide (substance)	Inferred relationship	Some	2
Product containing precisely hydrochlorothiazide 12.5 milligram and metoprolol tartrate 50 milligram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Hydrochlorothiazide (substance)	Inferred relationship	Some	2
Product containing precisely amiloride hydrochloride 2.5 milligram and hydrochlorothiazide 25 milligram and timolol maleate 10 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Hydrochlorothiazide (substance)	Inferred relationship	Some	3
Product containing precisely amiloride hydrochloride 2.5 milligram and hydrochlorothiazide 25 milligram and timolol maleate 10 milligram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Hydrochlorothiazide (substance)	Inferred relationship	Some	3
Product containing precisely amiloride hydrochloride 2.5 milligram and atenolol 50 milligram and hydrochlorothiazide 25 milligram/1 each conventional release oral capsule (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Hydrochlorothiazide (substance)	Inferred relationship	Some	3
Product containing precisely hydralazine hydrochloride 25 milligram and hydrochlorothiazide 25 milligram/1 each conventional release oral capsule (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Hydrochlorothiazide (substance)	Inferred relationship	Some	2
Product containing precisely hydralazine hydrochloride 50 milligram and hydrochlorothiazide 50 milligram/1 each conventional release oral capsule (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Hydrochlorothiazide (substance)	Inferred relationship	Some	1
Product containing precisely hydralazine hydrochloride 50 milligram and hydrochlorothiazide 50 milligram/1 each conventional release oral capsule (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Hydrochlorothiazide (substance)	Inferred relationship	Some	1
Hydrochlorothiazide 25 mg and methyldopa 250 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Hydrochlorothiazide (substance)	Inferred relationship	Some	2
Hydrochlorothiazide 25 mg and methyldopa 250 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Hydrochlorothiazide (substance)	Inferred relationship	Some	2
Hydrochlorothiazide 25 mg and propranolol hydrochloride 40 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Hydrochlorothiazide (substance)	Inferred relationship	Some	1
Hydrochlorothiazide 25 mg and propranolol hydrochloride 40 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Hydrochlorothiazide (substance)	Inferred relationship	Some	1
Hydrochlorothiazide 50 mg and reserpine 125 microgram oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Hydrochlorothiazide (substance)	Inferred relationship	Some	2
Hydrochlorothiazide 25 mg and propranolol hydrochloride 80 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Hydrochlorothiazide (substance)	Inferred relationship	Some	1
Hydrochlorothiazide 25 mg and propranolol hydrochloride 80 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Hydrochlorothiazide (substance)	Inferred relationship	Some	1
Hydrochlorothiazide 12.5 mg and telmisartan 80 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Hydrochlorothiazide (substance)	Inferred relationship	Some	2
Hydrochlorothiazide 12.5 mg and telmisartan 80 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Hydrochlorothiazide (substance)	Inferred relationship	Some	2
Product containing precisely fosinopril 10 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Hydrochlorothiazide (substance)	Inferred relationship	Some	2
Product containing precisely fosinopril 10 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Hydrochlorothiazide (substance)	Inferred relationship	Some	2
Product containing precisely eprosartan mesilate 600 milligram and hydrochlorothiazide 25 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Hydrochlorothiazide (substance)	Inferred relationship	Some	1
Product containing precisely eprosartan mesilate 600 milligram and hydrochlorothiazide 25 milligram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Hydrochlorothiazide (substance)	Inferred relationship	Some	1
Hydrochlorothiazide 12.5 mg and valsartan 320 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Hydrochlorothiazide (substance)	Inferred relationship	Some	2
Hydrochlorothiazide 12.5 mg and valsartan 320 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Hydrochlorothiazide (substance)	Inferred relationship	Some	2
Captopril 50 mg and hydrochlorothiazide 25 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Hydrochlorothiazide (substance)	Inferred relationship	Some	2
Captopril 50 mg and hydrochlorothiazide 25 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Hydrochlorothiazide (substance)	Inferred relationship	Some	2
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Hydrochlorothiazide (substance)	Inferred relationship	Some	3
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Hydrochlorothiazide (substance)	Inferred relationship	Some	3
Product containing precisely hydrochlorothiazide 12.5 milligram and irbesartan 300 milligram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Hydrochlorothiazide (substance)	Inferred relationship	Some	2
Product containing precisely hydrochlorothiazide 25 milligram and quinapril 20 milligram/1 each conventional release oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Hydrochlorothiazide (substance)	Inferred relationship	Some	1
Product containing precisely hydrochlorothiazide 25 milligram and quinapril 20 milligram/1 each conventional release oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Hydrochlorothiazide (substance)	Inferred relationship	Some	1
Hydrochlorothiazide 12.5 mg and valsartan 160 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Hydrochlorothiazide (substance)	Inferred relationship	Some	2
Product containing precisely fosinopril 20 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Hydrochlorothiazide (substance)	Inferred relationship	Some	2
Product containing hydralazine and hydrochlorothiazide (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Hydrochlorothiazide (substance)	Inferred relationship	Some	2
Product containing hydrochlorothiazide and labetalol (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Hydrochlorothiazide (substance)	Inferred relationship	Some	2
Product containing precisely hydrochlorothiazide 25 milligram and metoprolol tartrate 200 milligram/1 each prolonged-release oral tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Hydrochlorothiazide (substance)	Inferred relationship	Some	2
Product containing precisely hydrochlorothiazide 25 milligram and metoprolol tartrate 200 milligram/1 each prolonged-release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Hydrochlorothiazide (substance)	Inferred relationship	Some	2
Hydrochlorothiazide- and metoprolol-containing product in oral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Hydrochlorothiazide (substance)	Inferred relationship	Some	2
Amiloride hydrochloride 5 mg and hydrochlorothiazide 50 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Hydrochlorothiazide (substance)	Inferred relationship	Some	2
Product containing precisely aliskiren 150 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Hydrochlorothiazide (substance)	Inferred relationship	Some	2
Candesartan cilexetil 16 mg and hydrochlorothiazide 12.5 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Hydrochlorothiazide (substance)	Inferred relationship	Some	1
Captopril 25 mg and hydrochlorothiazide 25 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Hydrochlorothiazide (substance)	Inferred relationship	Some	1
Captopril 50 mg and hydrochlorothiazide 15 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Hydrochlorothiazide (substance)	Inferred relationship	Some	2
Benazepril hydrochloride 20 mg and hydrochlorothiazide 25 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Hydrochlorothiazide (substance)	Inferred relationship	Some	2
Aliskiren- and hydrochlorothiazide-containing product in oral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Hydrochlorothiazide (substance)	Inferred relationship	Some	1
Amiloride- and atenolol- and hydrochlorothiazide-containing product in oral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Hydrochlorothiazide (substance)	Inferred relationship	Some	3
Amiloride hydrochloride 2.5 mg and hydrochlorothiazide 25 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Hydrochlorothiazide (substance)	Inferred relationship	Some	2
Product containing precisely aliskiren 150 milligram and hydrochlorothiazide 25 milligram/1 each conventional release oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Hydrochlorothiazide (substance)	Inferred relationship	Some	1
Candesartan- and hydrochlorothiazide-containing product in oral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Hydrochlorothiazide (substance)	Inferred relationship	Some	2
Product containing acebutolol and hydrochlorothiazide in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Hydrochlorothiazide (substance)	Inferred relationship	Some	2
Product containing precisely hydrochlorothiazide 12.5 milligram and irbesartan 300 milligram/1 each conventional release oral tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Hydrochlorothiazide (substance)	Inferred relationship	Some	2
Product containing captopril and hydrochlorothiazide in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Hydrochlorothiazide (substance)	Inferred relationship	Some	2
Hydrochlorothiazide 12.5 mg and irbesartan 150 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Hydrochlorothiazide (substance)	Inferred relationship	Some	2
Product containing precisely bisoprolol 10 milligram and hydrochlorothiazide 6.25 milligram/1 each conventional release oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Hydrochlorothiazide (substance)	Inferred relationship	Some	2
Product containing precisely enalapril 10 milligram and hydrochlorothiazide 25 milligram/1 each conventional release oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Hydrochlorothiazide (substance)	Inferred relationship	Some	1
Hydrochlorothiazide 25 mg and spironolactone 25 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Hydrochlorothiazide (substance)	Inferred relationship	Some	2
Amiloride- and hydrochlorothiazide-containing product in oral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Hydrochlorothiazide (substance)	Inferred relationship	Some	2
Product containing precisely fosinopril 10 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Hydrochlorothiazide (substance)	Inferred relationship	Some	1
Hydrochlorothiazide 25 mg and triamterene 37.5 mg oral capsule	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Hydrochlorothiazide (substance)	Inferred relationship	Some	2
Hydrochlorothiazide 12.5 mg and valsartan 80 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Hydrochlorothiazide (substance)	Inferred relationship	Some	1
Benazepril hydrochloride 10 mg and hydrochlorothiazide 12.5 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Hydrochlorothiazide (substance)	Inferred relationship	Some	2
Hydrochlorothiazide 12.5 mg and valsartan 320 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Hydrochlorothiazide (substance)	Inferred relationship	Some	1
Product containing precisely enalapril 20 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Hydrochlorothiazide (substance)	Inferred relationship	Some	2
Product containing precisely amiloride hydrochloride 2.5 milligram and atenolol 50 milligram and hydrochlorothiazide 25 milligram/1 each conventional release oral capsule (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Hydrochlorothiazide (substance)	Inferred relationship	Some	3
Product containing benazepril and hydrochlorothiazide in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Hydrochlorothiazide (substance)	Inferred relationship	Some	2
Hydrochlorothiazide 25 mg and lisinopril 20 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Hydrochlorothiazide (substance)	Inferred relationship	Some	1
Product containing bisoprolol and hydrochlorothiazide in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Hydrochlorothiazide (substance)	Inferred relationship	Some	2
Product containing precisely enalapril 5 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Hydrochlorothiazide (substance)	Inferred relationship	Some	1
Product containing precisely hydrochlorothiazide 12.5 milligram and quinapril 20 milligram/1 each conventional release oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Hydrochlorothiazide (substance)	Inferred relationship	Some	2
Captopril 25 mg and hydrochlorothiazide 12.5 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Hydrochlorothiazide (substance)	Inferred relationship	Some	1
Benazepril hydrochloride 5 mg and hydrochlorothiazide 6.25 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Hydrochlorothiazide (substance)	Inferred relationship	Some	2
Benazepril hydrochloride 20 mg and hydrochlorothiazide 12.5 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Hydrochlorothiazide (substance)	Inferred relationship	Some	1
Hydrochlorothiazide 25 mg and losartan potassium 100 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Hydrochlorothiazide (substance)	Inferred relationship	Some	2
Product containing precisely aliskiren 300 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Hydrochlorothiazide (substance)	Inferred relationship	Some	2
Hydrochlorothiazide 25 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Hydrochlorothiazide (substance)	Inferred relationship	Some	1

Start Previous Page 4 of 8 Next End

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
1461703016	Hydrochlorothiazide (substance)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
1481615017	Hydrochlorothiazide	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
1492148015	HCTZ	en	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	SNOMED CT core